ANG1005 in Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- NA
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
- Status
- UNKNOWN
- Phase
- NA
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
- Status
- COMPLETED
- Phase
- PHASE1
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
- Status
- COMPLETED
- Phase
- NA
MET-PET for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Valproic Acid in Childhood Progressive Brain Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
- Status
- WITHDRAWN
- Phase
- PHASE1
MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
- Status
- TERMINATED
- Phase
- N/A
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Tivozanib for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2